Manchester Capital Management LLC
Position in TAK — Takeda Pharmaceutical Co Ltd
CIK 1393389
MANCHESTER, VT
Position in TAK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$74,523
-$11,576 QoQ
Shares Held
4,649
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#247
of 375 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 21%
Shared 0%
None 79%
Common Shares in TAK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Manchester Capital Management LLC holds $190,507 across 8 Drug Manufacturers - Specialty & Generic names. TAK ranks #1 (39.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TAK |
Takeda Pharmaceutical Co Ltd
This page
|
4,649 | $74,523 | |
| 2 | VTRS |
Viatris Inc
|
4,478 | $71,110 | |
| 3 | ZTS |
Zoetis Inc.
|
500 | $35,930 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
119 | $2,928 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
4 | $2,167 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
11 | $1,853 | |
| 7 | ALKS |
Alkermes plc.
|
20 | $1,048 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
28 | $948 |
All Filings in TAK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $74,523 | 4,649 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $86,099 | 4,649 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $72,477 | 4,649 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $35,560 | 2,429 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $37,521 | 2,427 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $33,279 | 2,238 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $29,022 | 2,192 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $28,880 | 2,031 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $23,499 | 1,816 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $6,694 | 482 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $6,878 | 482 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $10,287 | 665 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $11,279 | 718 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $9,311 | 565 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $8,814 | 565 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $6,523 | 503 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $11,625 | 828 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $11,914 | 832 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $8,750 | 642 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $10,761 | 657 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $8,381 | 498 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $12,197 | 668 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $12,157 | 668 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $11,917 | 668 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $11,977 | 668 | Shares | Sole | 2020-09-28 | |
| 2020-03-31 | $10,140 | 668 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||